张青
硕士生导师

职称：教授

学院：肿瘤生物治疗研究所
qingzhang@xzhmu.edu.cn







个人简介
张青，博士毕业于四川大学，美国北卡罗莱纳大学教堂山分校访问****。现任江苏省肿瘤生物治疗工程技术研究中心主任、江苏省肿瘤生物治疗工程实验室副主任、江苏省“青蓝工程”中青年学术带头人、江苏省“六大人才高峰”人才、江苏省双创团队核心成员、中国免疫学会会员、中国抗癌协会肿瘤标志专业委员会会员、江苏省免疫学会青年委员、江苏省移植与区域免疫专业委员会委员、江苏省研究型医院协会会员。任Cancer letter, Cellular signaling, Oncology reports, Molecular and Clinical Oncology等杂志审稿人。主要从事肿瘤微环境与免疫细胞治疗研究，主持国家自然基金和省部级课题10余项，以第一/通讯作者发表SCI论文20篇，申请发明专利6项。




发表论文:
Coagulation factors VII, IX and X are antibacterial proteins against drug-resistant Gram-negative bacteria

---

CAIX-specific CAR-T Cells and Sunitinib Show Synergistic Effects Against Metastatic Renal Cancer Models

---

Tumor-Penetrating Peptide Enhances Antitumor Effects of IL-24 Against Prostate Cancer

---

Modification of IL-24 by tumor penetrating peptide iRGD enhanced its antitumor efficacy against non-small cell lung cancer

---

Akt inhibition at the initial stage of CAR-T preparation enhances the CAR-positive expression rate, memory phenotype and in vivo efficacy

---

Lenvatinib promotes antitumor immunity by enhancing the tumor infiltration and activation of NK cells

---

Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models

---

Current status and future prospects of the strategy of combining

---

Bortezomib improves adoptive carbonic anhydrase IX-specific chimeric antigen receptor-modified NK92 cell therapy in mouse models of human renal cell carcinoma

---

Chimeric antigen receptor-T cell therapy for solid
教材专著:

科研项目:
表达肿瘤血管定位信号GPI-VEGFR-

---

人源化CAIX-CAR-T联合舒尼替尼治

---

分泌HPSE的两级靶向CAR-T细胞治

---

江苏省“青蓝工程”中青年学术带
获奖成果: